Evaluation and Recommendations on Good Clinical Laboratory Practice Guidelines for Phase I–III Clinical Trials
Open Access
- 5 May 2009
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLoS Medicine
- Vol. 6 (5) , e1000067
- https://doi.org/10.1371/journal.pmed.1000067
Abstract
Marcella Sarzotti-Kelsoe and colleagues harmonize various approaches to Good Clinical Laboratory Practice for clinical trials into a single set of recommendations.Keywords
This publication has 13 references indexed in Scilit:
- Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three ContinentsClinical and Vaccine Immunology, 2009
- Validation of a HLA-A2 tetramer flow cytometric method, IFNgamma real time RT-PCR, and IFNgamma ELISPOT for detection of immunologic response to gp100 and MelanA/MART-1 in melanoma patientsJournal of Translational Medicine, 2008
- Precision and linearity targets for validation of an IFNγ ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptidesBMC Immunology, 2008
- Guidelines on good clinical laboratory practice: Bridging operations between research and clinical research laboratoriesJournal of Pharmaceutical and Biomedical Analysis, 2007
- Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI)Cancer Immunology, Immunotherapy, 2007
- Toward the harmonization of immune monitoring in clinical trials: Quo vadis?Cancer Immunology, Immunotherapy, 2007
- Laboratory expansion to large-scale international HIV preventive vaccine trialsCurrent Opinion in HIV and AIDS, 2007
- Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccinationJournal of Immunological Methods, 2007
- Results of an ELISPOT Proficiency Panel Conducted in 11 Laboratories Participating in International Human Immunodeficiency Virus Type 1 Vaccine TrialsAIDS Research and Human Retroviruses, 2005
- Enhanced: The Need for a Global HIV Vaccine EnterpriseScience, 2003